Vzajemna zdravstvena zavarovalnica, d. d. (LJSE:VZZR)
Slovenia · Delayed Price · Currency is EUR 1.376
+0.026 (1.93%)
At close: Aug 11, 2026
LJSE:VZZR Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 33.84 | 30.3 | 22.97 | 19.96 | 334.5 |
Total Interest & Dividend Income | 1.96 | 2.35 | 2.35 | -2.47 | 1.69 |
Gain (Loss) on Sale of Investments | -1.97 | -0.78 | -0.26 | -0.49 | 0.25 |
Other Revenue | - | - | - | - | 0.57 |
| 33.84 | 31.88 | 25.06 | 17 | 337.01 | |
Revenue Growth | 6.16% | 27.18% | 47.42% | -94.95% | -5.78% |
Policy Benefits | 17.83 | 14.8 | 10.27 | 7.3 | 295.21 |
Policy Acquisition & Underwriting Costs | 9.42 | 10.09 | 3.18 | 2.04 | - |
Selling, General & Administrative | 6.89 | 7.56 | 1.59 | 0.95 | 30.99 |
Other Operating Expenses | 1.48 | 1.21 | 0.61 | -0.25 | 1.79 |
Total Operating Expenses | 35.62 | 33.66 | 15.64 | 10.03 | 327.99 |
Operating Income | -1.78 | -1.78 | 9.42 | 6.97 | 9.02 |
Interest Expense | -0.09 | -0.11 | -0.08 | -0 | -0.02 |
Earnings From Equity Investments | -0.02 | -0.08 | -0.35 | 1.73 | -1.56 |
Other Non Operating Income (Expenses) | 0.48 | 0.47 | 0.01 | -0.04 | 1.88 |
EBT Excluding Unusual Items | -1.41 | -1.51 | 9 | 8.66 | 9.32 |
Gain (Loss) on Sale of Investments | - | - | - | - | -0 |
Asset Writedown | - | -0.01 | -1.41 | 0 | - |
Pretax Income | -1.41 | -1.51 | 7.59 | 8.67 | 9.32 |
Income Tax Expense | -0.23 | 0.1 | -1.1 | 0.53 | 1.9 |
Earnings From Continuing Ops. | -1.17 | -1.62 | 8.69 | 8.14 | 7.42 |
Earnings From Discontinued Ops. | - | - | -27.86 | -5.41 | - |
Net Income to Company | -1.17 | -1.62 | -19.16 | 2.73 | 7.42 |
Minority Interest in Earnings | -0 | -0.02 | -0.02 | -0 | 0.01 |
Net Income | -1.18 | -1.64 | -19.18 | 2.73 | 7.43 |
Net Income to Common | -1.18 | -1.64 | -19.18 | 2.73 | 7.43 |
Net Income Growth | - | - | - | -63.25% | -37.35% |
Shares Outstanding (Basic) | 19 | 74 | - | - | - |
Shares Outstanding (Diluted) | 19 | 74 | - | - | - |
Shares Change | -74.80% | - | - | - | - |
EPS (Basic) | -0.06 | -0.02 | - | - | - |
EPS (Diluted) | -0.06 | -0.02 | - | - | - |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.55 | -21.12 | -55.09 | -8.8 | 18.36 |
Free Cash Flow Per Share | -0.25 | -0.29 | - | - | - |
Operating Margin | -5.25% | -5.60% | 37.60% | 41.00% | 2.68% |
Profit Margin | -3.48% | -5.14% | -76.52% | 16.05% | 2.20% |
Free Cash Flow Margin | -13.44% | -66.24% | -219.79% | -51.78% | 5.45% |
EBITDA | -0.85 | -1.03 | 11.55 | 8.89 | 9.98 |
EBITDA Margin | -2.50% | -3.24% | 46.08% | 52.31% | 2.96% |
D&A For EBITDA | 0.93 | 0.75 | 2.12 | 1.92 | 0.96 |
EBIT | -1.78 | -1.78 | 9.42 | 6.97 | 9.02 |
EBIT Margin | -5.25% | -5.60% | 37.60% | 41.00% | 2.68% |
Effective Tax Rate | - | - | - | 6.08% | 20.43% |